latest news releases from the newsroom
Akzo Nobel: Organon Moves U.S. Filing of Additional Data for Gepirone to 2003
ARNHEM and OSS, The Netherlands, Oct. 9, 2002 (PRIMEZONE) -- Akzo Nobel's (Nasdaq:AKZOY) human healthcare business, Organon, announces that it will take longer to complete the regulatory file for its new antidepressant drug, gepirone ER (previously known as Ariza), in the United States. It expects to submit the additional data required by the U.S. Food and Drug Administration (FDA) in the third quarter of 2003.
Karo Bio and Bristol-Myers Squibb Extend Obesity Collaboration
HUDDINGE, Sweden, Oct. 9, 2002 (PRIMEZONE) -- Karo Bio (Other OTC:KARBF) (Stockholm:KARO) and Bristol-Myers Squibb Company (NYSE:BMY) have been collaborating for development of a new obesity treatment by targeting the thyroid hormone receptor since 1997. The three-year collaboration has been prolonged for two years and the joint drug discovery collaboration, which should now have ended, is instead prolonged for an additional six months period. The collaboration has been successful in demonstrating proof of principle in relevant animal models and the collaboration is now focused on selection of a new clinical development candidate. The first compound in the clinic was abandoned in March this year due to safety reasons.
Telenor: Tax Return Challenged
OSLO, Norway, Oct. 9, 2002 (PRIMEZONE) -- The Central Tax Office for Large Enterprises has notified Telenor (Nasdaq:TELN) that it will suggest to its Assessment Board that the 2001 tax return for Telenor Communication AS, a Telenor Group company, may be challenged in respect of this company's sale of its shares in Sonofon Holding A/S to Dansk Mobil Holding AS, another Telenor Group company.
Enea Negotiates Reduced Salaries
TABY, Sweden, Oct. 9, 2002 (PRIMEZONE) -- Enea (Other OTC:EDTDF) has started negotiations with the local unions at Enea concerning a program for cost reduction including salaries and benefits.
Princess Margaret Hospital Poised to Change Radiotherapy Practice with Elekta's Next Generation Treatment Device
TORONTO, Oct. 8, 2002 (PRIMEZONE) -- An innovative radiotherapy treatment platform that integrates advanced imaging technologies and treatment delivery into one system is ready for installation at Princess Margaret Hospital. The new Elekta SYNERGY(TM) research system represents a new class of treatment machines that will address the long-standing challenges of organ motion and set-up error in radiotherapy, through high-quality, volumetric imaging and target localization. Ontario's Princess Margaret Hospital (PMH) is the first Canadian installation of the research system, which is equipped with X-ray volume imaging (XVI) technology.
Popeyes Chicken & Biscuits
Popeyes Chicken & Biscuits Brings Celebrity Chef Dinner to Atlanta
ATLANTA, Oct. 8, 2002 (PRIMEZONE) -- Popeyes(r) Chicken & Biscuits, a division of AFC Enterprises, Inc. (Nasdaq:AFCE) and the world's second-largest quick-service chicken concept, is proud to present six of the finest chefs from Louisiana to prepare an elegant representation of Louisiana cuisine in an informative and entertaining dinner event. The Popeyes Chicken & Biscuits Third Annual Culinary Celebration Benefit will be held on Sunday, October 13, from 6 p.m. to 9 p.m. at the King Plow Arts Center in Atlanta, Georgia. Featured chefs and restaurateurs will be Paul Prudhomme, John Folse, Leah Chase, Marcelle Bienvenu, R. L. Holmes and Randy Cheramie.